07 Jan 2001

ISDN-ratiopharm® 5; (ISDN-ratiopharm® 5 Tabletten) - Deutschland

Updated: 07 Jan 2001

ISDN-ratiopharm® 5; -20 | -40 | -60 | -80

ISDN-ratiopharm 5: Sublinguale Appl.: akuter Angina-pectoris-Anfall. ISDN-ratiopharm 20/40/60/80 mg: Prophylaxe u. Langzeitther. d. Angina pectoris. Ther. d. schweren chron. Herzinsuffizienz b. gleichz. Gabe v. Herzglykosiden, Diuretika, ACE-Hemmern, arteriellen Vasodilatatoren. Pulmonale Hypertonie.

ISDN-ratiopharm® 5; Description, Presentation and Dosage

ISDN-ratiopharm® 5; Description

ISDN-ratiopharm® 5; Drug Class Description

Andere Nitrate

ISDN-ratiopharm® 5; Drug Description

1 Tbl. enth.: Isosorbiddinitrat 5 mg.

ISDN-ratiopharm® 5; Generic Name

ISDN-ratiopharm® 5 Tabletten

ISDN-ratiopharm® 5; Presentation

ISDN-ratiopharm® 5; Presentation

ISDN-ratiopharm® 5; -20/-40/-60/-80

ISDN-ratiopharm® 5; Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

ISDN-ratiopharm® 5; Dosage

ISDN-ratiopharm® 5; Adult Dosage

D-Mannitol, Maisstärke, Lactose 1H2O, Mikrokristalline Cellulose, Siliciumdioxid, Copolyvidon, Talkum, Magnesiumstearat, Natriumcyclamat. trimethylammonioethyl)methacrylatchlorid], Triethylcitrat, Lactose 1H2O, Farbstoffe E 171, E 172, 20 mg/40 mg zusätzlich: Saccharose, Maisstärke, Gelatine.

ISDN-ratiopharm® 5; Child Dosage

ISDN-ratiopharm® 20/-40/-60/-80 Retardkapseln
Zus.: 1 Retardkps. enth.: Isosorbiddinitrat 20 mg/40 mg/60 mg/80 mg.
Weit. Bestandteile: Mikrokristalline Cellulose, Carmellose-Natrium, Poly(O-2-hydroxypropyl, O-methyl)cellulose, Siliciumdioxid, Poly[ethylacrylat-co-methylmethacrylat-co- (2-

ISDN-ratiopharm® 5; Precautions, Reactions and Contraindications

ISDN-ratiopharm® 5; Special Precautions

ISDN-ratiopharm® 5; Special Precautions

N 40 a-d

ISDN-ratiopharm® 5; Adverse Reactions

ISDN-ratiopharm® 5; Adverse Reactions

N 40

Related Drugs - Angiology

Back to top